Upcoming Meetings: Device Capitol Hill briefing
This article was originally published in The Gray Sheet
Device Capitol Hill briefing: Device industry associations sponsoring briefing for congressional staff on FDA regulation of medical devices Sept. 3 at the Rayburn House office building in preparation for congressional consideration of FDA reform legislation. A bill is expected to be marked up by the House Commerce Committee in September, while Senate FDA reform legislation is nearing floor debate. The briefing will include speakers from the Health Industry Manufacturers Association, Boston Scientific, U.S. Surgical and the Cook Group on the 510(k) and PMA approval process, review of device effectiveness and labeling, and challenges facing the U.S. medical device industry. For more information contact HIMA's Jeanne Wilton at 202/434-7211, Medical Device Manufacturers Association's Jeff Kimbell at 202/476-7150, or National Electrical Manufacturers Association's Bob Britain at 703/841-3241...
You may also be interested in...
Asking whether FDA’s decision to allow emergency use of two old anti-malarial drugs was ‘political’ misses the point. The issue already was political, and FDA’s action may well be the best way to keep some measure of federal control on supplies of a drug with important other uses.
Guidelines for health care providers could help prevent shortages as demand for possible treatments surge, groups say. Stakeholders also argue “Buy America” executive order would hamper drug access.
BD and BioMedomics have released a new rapid point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19.